Mersana Therapeutics (STU:0M4) YoY EPS Growth : 69.75% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Mersana Therapeutics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Mersana Therapeutics's YoY EPS Growth for the quarter that ended in Mar. 2024 was 69.75%.

Mersana Therapeutics's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was €-0.15.

Mersana Therapeutics YoY EPS Growth Historical Data

The historical data trend for Mersana Therapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mersana Therapeutics YoY EPS Growth Chart

Mersana Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

76.14

-100.85

-81.53

3.52

34.06

Mersana Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EPS Growth	Get a 7-Day Free Trial															9.33	16.54	46.75	64.58	69.75

Mersana Therapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Mersana Therapeutics's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(-1.357	-	-2.058)	/	\| -2.058 \|
=	34.06 %

Mersana Therapeutics's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EPS Growth (Q: Mar. 2024 )
=	(Earnings per Share (Diluted) (Q: Mar. 2024 )	-	Earnings per Share (Diluted) (Q: Mar. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2023 )) \|
=	(-0.147	-	-0.486)	/	\| -0.486 \|
=	69.75 %

Mersana Therapeutics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Mersana Therapeutics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Mersana Therapeutics (STU:0M4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mersana Therapeutics Inc (STU:0M4) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

MRSN:USA 0M4:Germany

Address

840 Memorial Drive, Cambridge, MA, USA, 02139

Website

https://www.mersana.com

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs include XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.

Mersana Therapeutics (STU:0M4) Headlines

No Headlines